secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001193125-24-211645
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra appoints Michael Alfieri as principal financial officer, Bruce Greenberg steps down
--------------------------------------------------------------------------------

- Michael Alfieri appointed as principal financial officer and principal accounting officer, effective Aug 31, 2024, via consulting agreement with Danforth Global, Inc.
- Bruce Greenberg stepped down from positions including SVP Finance, Interim CFO, and principal accounting officer as of Aug 31, 2024.
- Greenberg receives separation: six months base salary, lump-sum $125,895, and COBRA premium payments for up to six months.
- Greenberg will provide consulting services through Nov 30, 2024, with continued vesting of outstanding stock options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524211645/0001193125-24-211645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524211645/d862679d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-211645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer